Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Table S5 from ETx-22, a Novel Nectin-4–Directed Antibody–Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4–Expressing Tumors
  1. Home
  2. Publications
  3. Table S5 from ETx-22, a Novel Nectin-4–Directed Antibody–Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4–Expressing Tumors

Table S5 from ETx-22, a Novel Nectin-4–Directed Antibody–Drug Conjugate, Demonstrates Safety and Potent Antitumor Activity in Low-Nectin-4–Expressing Tumors

Authors:
  • MLMarc Lopez
    Marc Lopez
  • ECEmerence Crompot
    Emerence Crompot
  • EJEmmanuelle Josselin
    Emmanuelle Josselin
  • AFAnne Farina
    Anne Farina
  • MRMarion Rubis
    Marion Rubis
  • RCRemy Castellano
    Remy Castellano
  • JFJoanna Fares
    Joanna Fares
  • MWMaria Wehbe
    Maria Wehbe
  • YCYves Collette
    Yves Collette
  • ECEmmanuelle Charafe
    Emmanuelle Charafe
  • SBStéphanie Blanchin
    Stéphanie Blanchin
  • FRFrançois Romagne
    François Romagne

Open Access
Publisher website
Google Scholar
  • 16 March 2026
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2767-9764.31761998
Abstract
Supplementary Table 5 shows the analysis of average Drug Antibody Ratio in monkey plasma
Keywords
  • PRECLINICAL MODELS
  • XENOGRAFT MODELS
  • BIOLOGICAL AGENTS & THERAPIES
  • ANTIBODY-DRUG CONJUGATES
  • GENITOURINARY CANCERS
  • BLADDER CANCER
  • GYNECOLOGICAL CANCERS
  • OVARIAN CANCER
  • BREAST CANCER
  • PRECISION MEDICINE
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.